文献速递鼻科

嗅觉障碍问卷最小临床重要差异的建立

Establishing the minimal clinically important difference for the Questionnaire of Olfactory Disorders.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-05-02

本研究以慢性鼻窦炎(CRS)患者为对象,采用4种基于分布的方法计算嗅觉障碍问卷阴性陈述(QOD-NS)的最小临床重要差异(MCID)。128例患者术后QOD-NS平均改善4.3±11.0,基线异常者改善9.6±12.9(p<0.001)。各法MCID为2.6至8.6分,平均5.2分。

要点

  • QOD-NS的MCID按不同方法为2.6至8.6分,平均5.2分。
  • 基线QOD-NS异常者术后更易达到MCID。

核心结论

  • 基于分布法计算的QOD-NS的MCID范围为2.6至8.6分,平均为5.2分。
  • 按术前QOD-NS评分分层时,术前QOD-NS评分异常的患者多数可达到MCID。

研究设计与样本

  • 对慢性鼻窦炎(CRS)患者完成QOD-NS问卷。
  • 采用4种分布法计算MCID:二分之一标准差、均值标准误、Cohen效应量d及最小可检测变化,并取4者平均值。
  • 共分析128例患者。

主要发现

  • 全队列术后QOD-NS评分平均改善4.3±11.0。
  • 基线评分异常者术后平均改善9.6±12.9(p<0.001)。
  • 各法MCID:标准差法6.5、均值标准误法3.1、Cohen效应量d法2.6、最小可检测变化法8.6。
  • 全队列达到MCID的可能性为26%至51%,术前嗅觉异常者为49%至70%。

关键数值与推荐

  • QOD-NS的MCID:标准差法6.5分、均值标准误法3.1分、Cohen效应量d法2.6分、最小可检测变化法8.6分,平均5.2分。
  • 全队列术后QOD-NS改善4.3±11.0,基线异常者改善9.6±12.9(p<0.001)。

临床怎么用

  • 临床可用2.6至8.6分(平均5.2分)作为QOD-NS变化的参考阈值。
  • 评估术后嗅觉相关生活质量改善时应结合术前QOD-NS基线水平分层解读。

局限性

  • 仅采用基于分布的方法计算MCID,未报告基于锚定法的验证。
  • 研究对象为慢性鼻窦炎患者,结论外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Olfactory-specific quality of life (QOL) can be measured using the Questionnaire of Olfactory Disorders Negative Statements (QOD-NS). Changes in the QOD-NS after treatment can be difficult to interpret since there is no standardized definition of clinically meaningful improvement. METHODS: Patients with chronic rhinosinusitis (CRS) completed the QOD-NS. Four distribution-based methods were used to calculate the minimal clinically important difference (MCID): (1) one-half standard deviation (SD); (2) standard error of the mean (SEM); (3) Cohen's effect size (d) of the smallest unit of change; and (4) minimal detectable change (MDC). We also averaged all 4 of the scores together. Finally, the likelihood of achieving a MCID after sinus surgery using these methods, as well as average QOD-NS scores, was stratified by normal vs abnormal baseline QOD-NS scores. RESULTS: Outcomes were examined on 128 patients. The mean ± SD improvement in QOD-NS score after surgery was 4.3 ± 11.0 for the entire cohort and 9.6 ± 12.9 for those with abnormal baseline scores (p < 0.001). The MCID values using the different techniques were: (1) SD = 6.5; (2) SEM = 3.1; (3) d = 2.6; and (4) MDC = 8.6. The MCID score was 5.2 on average. For the total cohort analysis, the likelihood of reporting a MCID ranged from 26% to 51%, and 49% to 70% for patients reporting preoperative abnormal olfaction. CONCLUSION: Distribution-based MCID values of the QOD-NS range between 2.6 and 8.6 points, with an average of 5.2. When stratified by preoperative QOD-NS scores the majority of patients reporting abnormal preoperative QOD-NS scores achieved a MCID.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Mattos JL, Schlosser RJ, Mace JC, et al. Establishing the minimal clinically important difference for the Questionnaire of Olfactory Disorders. Int Forum Allergy Rhinol. 2018. PMID: 29719139. doi:10.1002/alr.22135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。